daptomycin 6 mg/kg IV
ApprovedTerminated 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Antimicrobial Prophylaxis
Conditions
Antimicrobial Prophylaxis
Trial Timeline
Jan 1, 2008 → Sep 1, 2008
NCT ID
NCT00572260About daptomycin 6 mg/kg IV
daptomycin 6 mg/kg IV is a approved stage product being developed by Merck for Antimicrobial Prophylaxis. The current trial status is terminated. This product is registered under clinical trial identifier NCT00572260. Target conditions include Antimicrobial Prophylaxis.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00572260 | Approved | Terminated |
Competing Products
1 competing product in Antimicrobial Prophylaxis
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Ceftobiprole | Basilea Pharmaceutica | Phase 1 | 28 |